1415477-02-9

Basic information

• Product Name: C₁₆H₁₂N₄
• Synonyms: C₁₆H₁₂N₄
• CAS NO: 1415477-02-9
• Molecular Weight: 260.298
• Mol File: 1415477-02-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₆H₁₂N₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₆H₁₂N₄(1415477-02-9)
• EPA Substance Registry System: C₁₆H₁₂N₄(1415477-02-9)

Safety Data

• Hazardous Substances Data: 1415477-02-9(Hazardous Substances Data)

Upstream product

• 504-24-5 4-aminopyridine 
• 14476-72-3 2-(2-oxo-2-phenylethyl)malononitrile 

Downstream Products

• 1415477-07-4 C₂₂H₁₇N₅ 

Relevant articles and documents

Synthesis and docking studies of novel antitumor benzimidazoles

In this work, the benzimidazole-pyrrole conjugates 6a-h and benzimidazole-tetracycles conjugates 12-14 were prepared. The cytotoxicity of the compounds 3, 4a-h, 6a-h, 8, 10 and 12-14 was tested against lung cancer cell line A549. Compound 6b exhibited higher activity than the bis-benzoxazole natural product (UK-1), the standard. The tested 4g,h, 6a-h, 10 and 12-14 exhibited remarkable cytotoxicity activity against breast cancer cell line MCF-7 with higher activity than tamoxifen. Furthermore, compound 4h was found to be also more potent than doxurubicin. The antitumor promotion activity of synthesized compounds 4g,h, 6a-h, 10 and 12-14 has been estimated by studying their possible inhibitory effects on EBV-EA activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Among the studied compounds, the inhibitory activities of compounds 8, 13 and 14 demonstrated strong inhibitory effects on the Epstein-Barr virus early antigen (EBV-EA) activation without showing any cytotoxicity on the Raji cells and their effects being stronger than that of a representative control, oleanolic acid. Moreover, the molecular docking of the new compounds into plasminogen activator (uPA) receptor has been in correlation with the antitumor activity. All synthesized compounds 3, 4a-h, 6a-h, 8, 10 and 12-14 were docked into same groove of the binding site of the native co-crystalized (4-iodobenzo[b]thiophene-2-carboxamidine) ligand (PDB code:1c5x) for activity explaination. Compounds 4h, 6b and 13, giving the best docking results, were further studied to estimate their effect on the level of uPA using AssayMax human urokinase (uPA) ELISA kit. In case of A549 cell line, compound 6 exhibited similar activity to MMC, and for MCF-7 cell line, compound 4h exhibited similar activity to doxorubicin, in inhibiting the expression of uPA.